ARCHIVES

Rall, FDA Chief On AACR Panel

This article is from The Cancer Letter archive.

Vol. 05 No. 17 | April 27, 1979

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

Palmetto Establishes Coverage For Thyroid Genomic Test

January 27, 2012

LeMaistre Blasts “Death Merchants’ In tobacco Industry

May 5, 1989

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

Obituary: Hayden Braine, 67, Blood Cell Transfusion Pioneer At Hopkins

November 19, 2010

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012